# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-216790
Filing Date
2026-05-11
Accepted
2026-05-11 16:13:28
Documents
60
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | catx-20260331.htm iXBRL | 10-Q | 1580459
2 | EX-31.1 | catx-ex31_1.htm | EX-31.1 | 16571
3 | EX-31.2 | catx-ex31_2.htm | EX-31.2 | 16555
4 | EX-32 | catx-ex32.htm | EX-32 | 12709
| Complete submission text file | 0001193125-26-216790.txt |  | 7301985

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | catx-20260331.xsd | EX-101.SCH | 1303156
64 | EXTRACTED XBRL INSTANCE DOCUMENT | catx-20260331_htm.xml | XML | 1139758

Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33407 | Film No.: 26963355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)